Showing results (191-200 of 793) with videos related to

Sort By:
Pageof 80
Acta Haematologica|June 20, 2023
Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease EvaluationJoselle Cook, Kishore Rajendran, Andrea Ferrero, et al.
Blood Advances|March 31, 2021
Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myelomaHarsh Parmar, Morie Gertz, Emilie Ingrid Anderson, et al.
The Application of Clinical Genetics|August 13, 2013
Candidate genes of Waldenström's macroglobulinemia: current evidence and researchGiada Bianchi, Antonio Sacco, Shaji Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effectsCynthia R Giver, Richard O Montes, Stephen Mittelstaedt, et al.
Blood|January 25, 2002
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantationAmelia A Langston, Istvan Redei, Angela M Caliendo, et al.
Blood Cancer Journal|December 15, 2020
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myelomaYanyan Gu, Benjamin G Barwick, Mala Shanmugam, et al.
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
Plos One|February 27, 2019
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft modelsTaofeek K Owonikoko, Guojing Zhang, Shenila B Lallani, et al.
Expert Review of Hematology|May 14, 2021
Selinexor for the treatment of patients with previously treated multiple myelomaClifton C Mo, Sundar Jagannath, Ajai Chari, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2026
The Evolution of Chimeric Antigen Receptor T-Cell, Bispecific Antibodies and Antibody-Drug Conjugates for the Treatment of Multiple MyelomaLorenzo Cani, Richa Parikh, Nisha S Joseph, et al.
Pageof 80